Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30
Published October 17, 2018 · Recall initiated: September 10, 2018
Summary
FDA records drug Class II recall D-0026-2019, published October 17, 2018 and initiated September 10, 2018. Recalling firm: Takeda Development Center Americas, Inc.; Status: Terminated; Reported quantity: 7,248 bottles; Lot: Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020. Class II means possible temporary or medically reversible effects, or a remote probability of serious health consequences.
Status when published: Terminated — openFDA updates weekly, so this field may not reflect the current status. Always confirm with the official notice.
What's the hazard
Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
What to do
Voluntary: Firm initiated · Letter
Get an email when a new FDA recall like this is published
Free. We only write when there's a new recall that matches. Unsubscribe in one click.
Recall details
- Manufacturer
- Takeda Development Center Americas, Inc.
- Distributor
- AR, LA, MS, NC, NJ, OH, PA, SC and Puerto Rico
- Lot
- Lot, expiry: A26004, exp Apr 2020; A26443 and A26444, exp Sep 2020
- Risk classification
- Class II
- Area (FDA)
- drug
- Country
- United States
Related recalls
- FDAAMITIZA (lubiprostone) capsules 8 mcg. 60-count bottle, Rx Only. Marketed by: Sucampo Pharma Americas, LLC,November 21, 2018
- FDATHYROID POWDER USP (Levothyroxine labeled range of 34.2-41.8mcg/grain; Liothyroine (correct spellingOctober 17, 2018
- FDAPrevacid 24HR (Lansoprazole) delayed-release capsules, 15 mg, 14 capsules per bottle in a carton containing 1October 17, 2018
- FDATHYROID POWDER USP, Full Strength (Levothyroxine labeled range of 103-125mcg/grain; Liothyroine (correctOctober 17, 2018
- FDASignature Reserve Bourbon Maple Blondie Ice Cream 14 FL OZ UPC 2113009912October 17, 2018
- FDAAmlodipine Besylate USP 10 mg Tablets, 1000-count bottles, Rx Only, Manufactured by: Cipla Ltd., Verna Goa,October 17, 2018
Questions about this recall
Was Actoplus met XR (pioglitazone and metformin HCl, extended-release) tablets, 15 mg/1000 mg, Rx Only, 30 tablet bottle, Distributed by: Takeda Pharmaceuticals America, Inc, Deerfield, IL 60015. NDC: 64764-510-30 recalled?
Yes. FDA published recall D-0026-2019 on October 17, 2018. Reported hazard: Defective Delivery System: tablets may be missing, in whole or in part, the laser drilled holes on the metformin core of the Actoplus met XR tablets.
What should I do if I have this product?
Voluntary: Firm initiated · Letter